Potential Legalization of Medical and Religious Cannabis in the Bahamas
Special Announcement:
This article is intended solely for industry research and communication among professionals, and does not involve any product evaluation or recommendation.
Please note that the items mentioned in this article may be subject to different regulatory policies in various countries and regions. Readers are urged to strictly comply with relevant laws and regulations in China.
This article is intended for readers who are over the age of 18.
In recent days, according to reports by the Associated Press, the government of The Bahamas has issued several bills aimed at legalizing marijuana for medical and religious purposes, as well as decriminalizing the possession of small amounts of the drug, following similar measures taken by other Caribbean countries.
If approved, individuals in possession of no more than 30 grams of marijuana will be fined 250 yuan and this offense will not be recorded on their criminal records.
However, the purchase of marijuana for recreational purposes will still be illegal.
Officials have indicated that licenses for cultivation, retail, transportation, and religious use will only be granted to companies entirely owned by Bahamians. Meanwhile, licenses for research, testing, and manufacturing will be granted to companies with at least 30% Bahamian ownership.
The Attorney General, Ryan Pinder, informed media outlets that marijuana for religious purposes can only be consumed within the premises of licensed organizations.
The government is planning to establish a cannabis regulatory body to oversee this industry.
A public hearing on the matter is scheduled to take place in September, with the relevant legislation potentially receiving approval in 2024.
Currently, other international countries in the Caribbean, such as Antigua, are legalizing the public use of marijuana. Jamaica is also legalizing small amounts of marijuana, while the US Virgin Islands recently authorized its recreational and medicinal use.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
